Michelle Guignet

8PUBLICATIONS
12CO-AUTHORS
Electrical circuits and systemsNeurology and neuromuscular diseasesToxicology (incl. clinical toxicology)Neural engineeringPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 02, 2026
Preclinical signal for a disease-modifying effect on seizure cluster severity with intermittent diazepam treatment.

Qian Wu, Michelle Guignet, Jonathan Vuong

|Sep 27, 2025
Potential for Therapeutic Alteration of the Underlying Biology of Epilepsy.

Michael R Sperling, Jurriaan M Peters, Qian Wu

|Jun 02, 2025
Challenging the preclinical paradigm: Adverse effects of antiseizure medicines in male rats with drug-resistant epilepsy.

Michelle Guignet, Jonathan Vuong, Nicholas Uribe

|Mar 28, 2025
Intestinal dysbiosis alters acute seizure burden and antiseizure medicine activity in Theiler's virus model of encephalitis.

Inga Erickson, Stephanie Davidson, Hanna Choi

|Jun 14, 2024
Development of a novel dosing paradigm to model diazepam rescue therapy in preclinical seizure and epilepsy models.

Michelle Guignet, H Steve White, Sunita N Misra

|Nov 30, 2023
Temporal relationship between levetiracetam nonadherence and breakthrough seizures in a preclinical model of temporal lobe epilepsy.

Michelle Guignet, Jonathan Vuong, Alejandra Martinez

Pageof 2

Frequent Collaborators

3 joint publications

H Steve White

3 joint publications

Adrian L Rabinowicz

2 joint publications

Enrique Carrazana

2 joint publications

Qian Wu